[1]邵世珂,朱贤龙,董文胜,等.动脉瘤性蛛网膜下腔出血术后1年预后预测模型的构建和验证[J].中国临床神经外科杂志,2024,29(09):532-536540.[doi:10.13798/j.issn.1009-153X.2024.09.005]
 SHAO Shi-ke,ZHU Xian-long,DONG Wen-sheng,et al.Construction and validation of a prognostic model for one-year outcomes of patients with aneurysmal subarachnoid hemorrhage after surgery[J].,2024,29(09):532-536540.[doi:10.13798/j.issn.1009-153X.2024.09.005]
点击复制

动脉瘤性蛛网膜下腔出血术后1年预后预测模型的构建和验证()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
29
期数:
2024年09期
页码:
532-536540
栏目:
论著
出版日期:
2024-09-30

文章信息/Info

Title:
Construction and validation of a prognostic model for one-year outcomes of patients with aneurysmal subarachnoid hemorrhage after surgery
文章编号:
1009-153X(2024)09-0532-05
作者:
邵世珂朱贤龙董文胜尹鹏陈德顺樊拥军仲崇佩
222000 江苏连云港,南京医科大学康达学院附属连云港市第二人民医院神经外科(邵世珂、朱贤龙、董文胜、尹 鹏、陈德顺、樊拥军、仲崇佩)
Author(s):
SHAO Shi-ke ZHU Xian-long DONG Wen-sheng YIN Peng CHEN De-shun FAN Yong-jun ZHONG Chong-pei
Department of Neurosurgery, The Second People's Hospital of Lianyungang, Kangda College of Nanjing Medical University, Lianyungang 222000, China
关键词:
动脉瘤性蛛网膜下腔出血预后危险因素预测模型
Keywords:
Aneurysmal subarachnoid hemorrhage Prognosis Risk factors Prediction model
分类号:
R 743.9; R 651.1+2
DOI:
10.13798/j.issn.1009-153X.2024.09.005
文献标志码:
A
摘要:
目的 探讨动脉瘤性蛛网膜下腔出血(aSAH)术后1年预后的影响因素,并构建列线图模型进行验证。方法 回顾性分析2018年3月至2023年12月手术治疗的180例aSAH的临床资料。术后1年,采用改良Rankin量表评分评估预后,其中0~2分为预后良好,≥3为预后不良。采用lasso和logistic模型筛选预后影响因素,并使用列线图和受试者工作特征(ROC)曲线进行验证。结果 术后1年,62例预后不良,118例预后良好。单因素分析显示,年龄、改良Fisher分级、再出血、脑积水、入院时GCS、Hunt-Hess分级、动脉瘤形状与病人预后有关(P<0.05)。lasso回归及多因素logistic回归分析显示,年龄≥60岁(OR=2.228;95% CI 1.045~4.746;P=0.038)、入院时GCS评分≤8分(OR=4.104;95% CI 1.376~12.225;P=0.012)、术前Hunt-Hess分级≥3级(OR=4.382;95% CI 2.001~9.572;P<0.001 )是aSAH术后1年预后不良的独立危险因素。以这3个危险因素构建列线图模型,ROC曲线分析显示列线图模型预测预后不良的曲线下面积为0.794(95% CI 0.723~0.866),敏感度为771,特异度为742。结论 入院时GCS评分≤8分、入院时Hunt-Hess分级≥3级、年龄≥60岁是aSAH术后1年预后不良的独立危险因素,根据这些指标建立的预测模型对病人的预后表现出较高的预测效能。
Abstract:
Objective To investigate the risk factors affecting the 1-year prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH) following surgery and to develop a nomogram model for validation. Methods The clinical data of 180 patients with aSAH who underwent surgery from March 2018 to December 2023 were retrospectively analyzed. One year post-surgery, the prognosis was assessed using the modified Rankin Scale score, where scores of 0~2 indicated a good prognosis and ≥3 indicated a poor prognosis. Lasso and logistic regression models were utilized to identify the factors influencing prognosis, and the nomogram and receiver operating characteristic (ROC) curve were employed for validation. Results One year post-surgery, 62 patients had a poor prognosis, and 118 had a good prognosis. Univariate analysis revealed that age, preoperative modified Fisher grade, rebleeding, hydrocephalus, Glasgow Coma Scale (GCS) score on admission, preoperative Hunt-Hess grade, and aneurysm shape were significantly associated with aSAH patient prognosis (P<0.05). Lasso regression and multivariate logistic regression analysis demonstrated that age ≥60 years (OR=2.228; 95% CI 1.045~4.746; P=0.038), GCS score ≤8 on admission (OR=4.104; 95% CI 1.376~12.225; P=0.012), and preoperative Hunt-Hess grade ≥3 (OR=4.382; 95% CI 2.001~9.572; P<0.001) were independent risk factors for a poor prognosis of patients with aSAH one year after surgery. A nomogram model was constructed based on these three risk factors. ROC curve analysis indicated that the area under the curve for predicting a poor prognosis using the nomogram model was 0.794 (95% CI 0.723~0.866), with a sensitivity of 77.1% and a specificity of 74.2%. Conclusion A GCS score ≤8 on admission, a preoperative Hunt-Hess grade ≥3, and age ≥60 years are independent risk factors for a poor prognosis of patients with aSAH one year after surgery. The prediction model based on these indicators demonstrates high predictive efficacy for patient prognosis.

参考文献/References:

[1]HOH BL, KO NU, AMIN-HANJANI S, et al. 2023 Guideline forthe management of patients with aneurysmal subarachnoid hemo-rrhage: a guideline from the American Heart Association/American Stroke Association[J]. Stroke, 2023, 54(7): e314-e370.
[2]ROQUER J, CUADRADO-GODIA E, GUIMARAENS L, et al. Short- and long-term outcome of patients with aneurysmal sub-arachnoid hemorrhage[J]. Neurology, 2020, 95(13): e1819-e1829.
[3]SHEN J, YU J, HUANG S, et al. Scoring model to predict functionaloutcome in poor-grade aneurysmal subarachnoid hemorrhage[J]. Front Neurol, 2021, 12: 601996-602005.
[4]D'SOUZA S. Aneurysmal subarachnoid hemorrhage[J]. J Neuro-surg Anesthesiol, 2015, 27(3): 222-240.
[5]LI S, ZHANG J, LI N, et al. Predictive nomogram models for unfavorable prognosis after aneurysmal subarachnoid hemorrhage: analysis from a prospective, observational cohort in China[J]. CNS Neurosci Ther, 2023, 29(11): 3567-3578.
[6]NEIFERT SN, CHAPMAN EK, MARTINI ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade[J]. Transl Stroke Res,2021, 12(3): 428-446.
[7]Rinkel GJ, Ruigrok YM. Preventive screening for intracranial aneurysms[J]. Int J Stroke, 2022, 17(1): 30-36.
[8]AKIYAMA R, IMAMURA H, TANI S, et al. Outcomes of endova-scular therapy versus microsurgical treatment for aneurysmal sub-arachnoid hemorrhage in patients ≥70 years of age[J]. J Neuro-endovasc Ther, 2020, 14(1): 1-7.
[9]HAMMER A, RANAIE G, YAKUBOV E, et al. Dynamics of outcome after aneurysmal subarachnoid hemorrhage[J]. Aging (Albany NY), 2020, 12(8): 7207-7217.
[10]BECERRIL-GAITAN A, NGUYEN T, LIU C, et al. The effect of age on cerebral vasospasm and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2024, 187: e1017-e1024.
[11]LIU XN, ZHANG YQ, CHEN F, et al. Association between sudden onset in confined spaces and disease severity and short-term clinical outcomes in patients with aneurysmal subarachnoid hemorrhage[J]. Acad J Chin PlA Med School, 2023, 44(3): 234-238.刘学妮,张轶群,陈 峰,等. 密闭空间发病与动脉瘤性蛛网膜下腔出血患者病情严重程度及短期预后的相关性分析[J]. 解放军医学院学报,2023,44(3):234-238.
[12]BAE IS, CHUN HJ, CHOI KS, et al. Modified Glasgow coma scale for predicting outcome after subarachnoid hemorrhage surgery[J]. Medicine (Baltimore), 2021, 100(19): e25815-e25822.
[13]SCHMIDT TP, WEISS M, HOELLIG A, et al. Revisiting the time-line of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: toward a temporal risk profile[J]. Neurocrit Care, 2022, 37(3): 735-743.
[14]XU K, HAN C, DING SL, et al. Factors of preoperative rebleeding in 181 patients with poor-grade aneurysmal subarachnoid hemorrhage[J]. J Shandong Univer (Health Sci), 2022, 60(9): 97-101.胥  凯,韩 超,丁守銮,等. 181例高分级动脉瘤性蛛网膜下腔出血病人术前再出血的影响因素[J]. 山东大学学报(医学版),2022,60(9):97-101.

相似文献/References:

[1]于 涛 黄正通 王振宇.椎管内脊膜囊肿的临床特征和治疗方法[J].中国临床神经外科杂志,2015,(11):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
 YU Tao,HUANG Zheng-tong,WANG Zhen-yu.Clinical features and treatment of intraspinal arachnoid cysts[J].,2015,(09):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
[2]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(09):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[3]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
 XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(09):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[4]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
 ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(09):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[5]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
 CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(09):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[6]申彦杰 宋 健 成文平 程东亮.微血管减压术治疗面肌痉挛57例[J].中国临床神经外科杂志,2016,(04):238.[doi:10.13798/j.issn.1009-153X.2016.04.016]
[7]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[8]郭 芳 张 铭 李中振 梁恩和.动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的危险因素分析[J].中国临床神经外科杂志,2016,(02):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
 GUO Fang,ZHANG Ming,LI Zhong-zhen,et al.Risk factors related to shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J].,2016,(09):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
[9]李玉龙 方兴根 李真保 吴德刚 赖年升 赵心同 徐善水 狄广福.血管内治疗颈内动脉床突旁破裂动脉瘤[J].中国临床神经外科杂志,2016,(02):79.[doi:10.13798/j.issn.1009-153X.2016.02.006]
 LI Yu-long,FANG Xing-gen,LI Zhen-bao,et al.Endovascular embolization of ruptured paraclinoid aneurysms (report of 26 cases)[J].,2016,(09):79.[doi:10.13798/j.issn.1009-153X.2016.02.006]
[10]皮水平 刘 杰 黄前樟.长期服用抗凝药物的老年颅脑损伤患者治疗体会[J].中国临床神经外科杂志,2016,(02):117.[doi:10.13798/j.issn.1009-153X.2016.02.022]
[11]阮 东 王 芳 郭丽蕊 彭红梅 陈谦学 刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
 RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[12]张 兰 库洪彬 王 敏 周 燕.动脉瘤性蛛网膜下腔出血病人血清sLOX-1、netrin-1水平变化及其与病人预后的关系[J].中国临床神经外科杂志,2020,(06):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
 ZHANG Lan,KU Hong-bin,WANG Min,et al.Relationship between serum levels of sLOX-1 and netrin-1 and progosis of patients with aneurysmal subarachnoid hemorrhage[J].,2020,(09):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
[13]史祥玉 王守森 望家兴 田 君 彭慧平.SII和PNI与动脉瘤性蛛网膜下腔出血预后的关系[J].中国临床神经外科杂志,2022,27(03):167.[doi:10.13798/j.issn.1009-153X.2022.03.007]
 SHI Xiang-yu,WANG Shou-sen,WANG Jia-xing,et al.Relationship between SNI and PNI with prognosis of patients with aneurysmal subarachnoid hemorrhage[J].,2022,27(09):167.[doi:10.13798/j.issn.1009-153X.2022.03.007]
[14]任江艳,王新星,王向阳,等.血清miR-193b-3p与动脉瘤性蛛网膜下腔出血病人不良预后的关系[J].中国临床神经外科杂志,2023,28(09):569.[doi:10.13798/j.issn.1009-153X.2023.09.007]
 REN Jiang-yan,WANG Xin-xing,WANG Xiang-yang,et al.Relationship between serum miR-193b-3p on admition and poor prognosis of patients with aneurysmal subarachnoid hemorrhage[J].,2023,28(09):569.[doi:10.13798/j.issn.1009-153X.2023.09.007]
[15]张国庆,吴志平,郑丹,等.高分级颅内破裂动脉瘤血管内介入治疗预后的影响因素[J].中国临床神经外科杂志,2023,28(10):649.[doi:10.13798/j.issn.1009-153X.2023.10.012]

备注/Memo

备注/Memo:
(2024-05-13收稿,2024-08-06修回)
基金项目:江苏省基础研究计划自然科学基金(BK20211275)
通信作者:仲崇佩,Email:zcp130809@163.com
更新日期/Last Update: 2024-09-30